Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy

M. Ohta, Makoto Hashizume, K. Ueno, K. Tanoue, K. Sugimachi

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In attemps to avoid hemolytic nephropathy following injection of 5 % ethanolamine oleate during endoscopic injection sclerotherapy for esophageal varices, the relationship between serum levels of albumin and hemolysis induced by ethanolamine oleate was investigated. The rate of hemolysis at various concentrations of ethanolamine oleate and albumin was examined using a spectrophotometer in ten cirrhotic patients and five healthy volunteers (controls). Hemolysis induced by ethanol-amine oleate increased in an ethanolamine oleate concentration-dependent fashion (p<0.01) but was dose-dependently inhibited by albumin (p < 0.05). The state of liver function was unrelated to the rate of hemolysis. The relationship between hemoglobinuria and serum albumin levels in seventy-nine cirrhotic patients with esophageal varices treated by endoscopic injection sclerotherapy with ethanolamine oleate was also examined. Hemoglobinuria was evident in 20 out of 24 patients (83.8 %) in whom the serum albumin level was less than 3.0g/dl, and in 24 out of 55 (43.6 %) in whom it exceeded 3.0 g /dl, the difference being statistically significant (p< 0.01). On the day after endoscopic injection sclerotherapy, creatinine clearance fell from 81.6 ± 33.8 m/l min to 60.1±31.4ml/min in the hemoglobinuria-positive patients (p > 0.01) and two went into acute renal failure. The creatinine clearance ranged from 79.5 ± 27.9 ml/min to 83.0 ± 39.9 ml/min in the hemoglobinuria-negative patients (p<0.1). In the light of this evidence we correct the serum albumin level cut off point to 3.0g/dl prior to endoscopic injection sclerotherapy in order to maintain renal function.

Original languageEnglish
Pages (from-to)65-68
Number of pages4
JournalHepato-gastroenterology
Volume40
Issue number1
Publication statusPublished - Jan 1 1993

Fingerprint

Sclerotherapy
Hemolysis
Albumins
Erythrocytes
Injections
Serum Albumin
Hemoglobinuria
Esophageal and Gastric Varices
Oleic Acid
Acute Kidney Injury
Amines
Creatinine
Healthy Volunteers
Ethanol
Kidney
ethanolamine oleate

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy. / Ohta, M.; Hashizume, Makoto; Ueno, K.; Tanoue, K.; Sugimachi, K.

In: Hepato-gastroenterology, Vol. 40, No. 1, 01.01.1993, p. 65-68.

Research output: Contribution to journalArticle

Ohta, M, Hashizume, M, Ueno, K, Tanoue, K & Sugimachi, K 1993, 'Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy', Hepato-gastroenterology, vol. 40, no. 1, pp. 65-68.
Ohta, M. ; Hashizume, Makoto ; Ueno, K. ; Tanoue, K. ; Sugimachi, K. / Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy. In: Hepato-gastroenterology. 1993 ; Vol. 40, No. 1. pp. 65-68.
@article{d2e2f632c73b4776ba20eb3f505ea745,
title = "Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy",
abstract = "In attemps to avoid hemolytic nephropathy following injection of 5 {\%} ethanolamine oleate during endoscopic injection sclerotherapy for esophageal varices, the relationship between serum levels of albumin and hemolysis induced by ethanolamine oleate was investigated. The rate of hemolysis at various concentrations of ethanolamine oleate and albumin was examined using a spectrophotometer in ten cirrhotic patients and five healthy volunteers (controls). Hemolysis induced by ethanol-amine oleate increased in an ethanolamine oleate concentration-dependent fashion (p<0.01) but was dose-dependently inhibited by albumin (p < 0.05). The state of liver function was unrelated to the rate of hemolysis. The relationship between hemoglobinuria and serum albumin levels in seventy-nine cirrhotic patients with esophageal varices treated by endoscopic injection sclerotherapy with ethanolamine oleate was also examined. Hemoglobinuria was evident in 20 out of 24 patients (83.8 {\%}) in whom the serum albumin level was less than 3.0g/dl, and in 24 out of 55 (43.6 {\%}) in whom it exceeded 3.0 g /dl, the difference being statistically significant (p< 0.01). On the day after endoscopic injection sclerotherapy, creatinine clearance fell from 81.6 ± 33.8 m/l min to 60.1±31.4ml/min in the hemoglobinuria-positive patients (p > 0.01) and two went into acute renal failure. The creatinine clearance ranged from 79.5 ± 27.9 ml/min to 83.0 ± 39.9 ml/min in the hemoglobinuria-negative patients (p<0.1). In the light of this evidence we correct the serum albumin level cut off point to 3.0g/dl prior to endoscopic injection sclerotherapy in order to maintain renal function.",
author = "M. Ohta and Makoto Hashizume and K. Ueno and K. Tanoue and K. Sugimachi",
year = "1993",
month = "1",
day = "1",
language = "English",
volume = "40",
pages = "65--68",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "1",

}

TY - JOUR

T1 - Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy

AU - Ohta, M.

AU - Hashizume, Makoto

AU - Ueno, K.

AU - Tanoue, K.

AU - Sugimachi, K.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - In attemps to avoid hemolytic nephropathy following injection of 5 % ethanolamine oleate during endoscopic injection sclerotherapy for esophageal varices, the relationship between serum levels of albumin and hemolysis induced by ethanolamine oleate was investigated. The rate of hemolysis at various concentrations of ethanolamine oleate and albumin was examined using a spectrophotometer in ten cirrhotic patients and five healthy volunteers (controls). Hemolysis induced by ethanol-amine oleate increased in an ethanolamine oleate concentration-dependent fashion (p<0.01) but was dose-dependently inhibited by albumin (p < 0.05). The state of liver function was unrelated to the rate of hemolysis. The relationship between hemoglobinuria and serum albumin levels in seventy-nine cirrhotic patients with esophageal varices treated by endoscopic injection sclerotherapy with ethanolamine oleate was also examined. Hemoglobinuria was evident in 20 out of 24 patients (83.8 %) in whom the serum albumin level was less than 3.0g/dl, and in 24 out of 55 (43.6 %) in whom it exceeded 3.0 g /dl, the difference being statistically significant (p< 0.01). On the day after endoscopic injection sclerotherapy, creatinine clearance fell from 81.6 ± 33.8 m/l min to 60.1±31.4ml/min in the hemoglobinuria-positive patients (p > 0.01) and two went into acute renal failure. The creatinine clearance ranged from 79.5 ± 27.9 ml/min to 83.0 ± 39.9 ml/min in the hemoglobinuria-negative patients (p<0.1). In the light of this evidence we correct the serum albumin level cut off point to 3.0g/dl prior to endoscopic injection sclerotherapy in order to maintain renal function.

AB - In attemps to avoid hemolytic nephropathy following injection of 5 % ethanolamine oleate during endoscopic injection sclerotherapy for esophageal varices, the relationship between serum levels of albumin and hemolysis induced by ethanolamine oleate was investigated. The rate of hemolysis at various concentrations of ethanolamine oleate and albumin was examined using a spectrophotometer in ten cirrhotic patients and five healthy volunteers (controls). Hemolysis induced by ethanol-amine oleate increased in an ethanolamine oleate concentration-dependent fashion (p<0.01) but was dose-dependently inhibited by albumin (p < 0.05). The state of liver function was unrelated to the rate of hemolysis. The relationship between hemoglobinuria and serum albumin levels in seventy-nine cirrhotic patients with esophageal varices treated by endoscopic injection sclerotherapy with ethanolamine oleate was also examined. Hemoglobinuria was evident in 20 out of 24 patients (83.8 %) in whom the serum albumin level was less than 3.0g/dl, and in 24 out of 55 (43.6 %) in whom it exceeded 3.0 g /dl, the difference being statistically significant (p< 0.01). On the day after endoscopic injection sclerotherapy, creatinine clearance fell from 81.6 ± 33.8 m/l min to 60.1±31.4ml/min in the hemoglobinuria-positive patients (p > 0.01) and two went into acute renal failure. The creatinine clearance ranged from 79.5 ± 27.9 ml/min to 83.0 ± 39.9 ml/min in the hemoglobinuria-negative patients (p<0.1). In the light of this evidence we correct the serum albumin level cut off point to 3.0g/dl prior to endoscopic injection sclerotherapy in order to maintain renal function.

UR - http://www.scopus.com/inward/record.url?scp=0027509713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027509713&partnerID=8YFLogxK

M3 - Article

C2 - 8462932

AN - SCOPUS:0027509713

VL - 40

SP - 65

EP - 68

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 1

ER -